NFKB1 and acute promyelocytic leukemia: The effect of NF-κB inhibition should stimulate more detailed studies on the importance of NF-κB for APL cell survival, the mechanisms by which NF-κB inhibition induces cell death and whether NF-κB inhibition can be used as adjunct therapy in APL [64, 65].